Literature DB >> 22965700

Effects of different therapeutic methods and typical recipes of Chinese medicine on activation of c-Jun N-terminal kinase in kupffer cells of rats with fatty liver disease.

Qin-He Yang1, Si-Ping Hu, Yu-Pei Zhang, Huan-Huan Ping, Huan-Wen Yang, Tong-Yan Chen, Hai-Tao Liu.   

Abstract

OBJECTIVE: To observe the effects of different therapeutic methods and the recipes of Chinese medicine (CM) on the activation of c-Jun N-terminal kinase (JNK) in Kupffer cells of rats with fatty liver disease and to explore the mechanisms of these therapeutic methods.
METHODS: By using a random number table, 98 rats were randomly divided into 7 groups: control group, model group, and 5 treatment groups, including soothing Liver (Gan) recipe group, invigorating Spleen (Pi) recipe group, dispelling dampness recipe group, promoting blood recipe group, and complex recipe group. Rats in the control group were fed with normal food and distilled water by gastric perfusion, while rats in the model group were fed with high-fat food and distilled spirits by gastric perfusion. Rats in the 5 treatment groups were fed with high-fat food and corresponding recipes by gastric perfusion. Twelve weeks later, all rats were sacrificed and liver tissues were stained for pathohistological observation. Kupffer cells were isolated from livers of rats to evaluate JNK and phospho-JNK expressions by Western blotting.
RESULTS: The grade of hepatic steatosis was higher in the model group than the control group (P<0.05). Compared with the model group, the grade of fatty degeneration in soothing Liver recipe group and invigorating Spleen recipe group were significantly ameliorated (P<0.05). Expressions of JNK and phospho-JNK in Kupffer cells were significantly higher in the model group than those in the control group (P<0.05, P<0.01). Compared with the model group, expressions of JNK in all treatment groups decreased, especially in invigorating Spleen recipe group and promoting blood recipe group (P<0.05). Compared with the model group, expressions of phospho-JNK in all treatment groups declined significantly (P<0.01), especially in soothing Live recipe group and invigorating Spleen recipe group.
CONCLUSIONS: The high expressions of JNK and phospho-JNK in Kupffer cells might play an important role in the pathogenesis of fatty liver disease in rats. The recipes of CM, especially invigorating Spleen recipe and soothing Liver recipe, might protect liver against injury by reducing the total JNK protein content and inhibiting the activation of JNK protein in Kupffer cells of fatty liver model rats, which showed beneficial effects on fatty liver disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22965700     DOI: 10.1007/s11655-011-0691-5

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  14 in total

Review 1.  The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs).

Authors:  R K Barr; M A Bogoyevitch
Journal:  Int J Biochem Cell Biol       Date:  2001-11       Impact factor: 5.085

Review 2.  The JNK signal transduction pathway.

Authors:  Claire R Weston; Roger J Davis
Journal:  Curr Opin Cell Biol       Date:  2007-02-15       Impact factor: 8.382

Review 3.  Pathology of steatohepatitis.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-10       Impact factor: 3.043

4.  Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice.

Authors:  K Tomita; G Tamiya; S Ando; K Ohsumi; T Chiyo; A Mizutani; N Kitamura; K Toda; T Kaneko; Y Horie; J-Y Han; S Kato; M Shimoda; Y Oike; M Tomizawa; S Makino; T Ohkura; H Saito; N Kumagai; H Nagata; H Ishii; T Hibi
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

5.  Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis.

Authors:  Harmeet Malhi; Steven F Bronk; Nathan W Werneburg; Gregory J Gores
Journal:  J Biol Chem       Date:  2006-02-27       Impact factor: 5.157

Review 6.  Regulation of Kupffer cell activity during chronic ethanol exposure: role of adiponectin.

Authors:  Pil-Hoon Park; Varsha Thakur; Michele T Pritchard; Megan R McMullen; Laura E Nagy
Journal:  J Gastroenterol Hepatol       Date:  2006-10       Impact factor: 4.029

7.  Leptin enhances TNF-alpha production via p38 and JNK MAPK in LPS-stimulated Kupffer cells.

Authors:  Jinhua Shen; Isao Sakaida; Koichi Uchida; Shuji Terai; Kiwamu Okita
Journal:  Life Sci       Date:  2005-08-12       Impact factor: 5.037

8.  The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.

Authors:  Stephen A Harrison; Sigurd Torgerson; Paul H Hayashi
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

9.  Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution.

Authors:  Lucia Malaguarnera; Michelino Di Rosa; Michelino D Rosa; Anna M Zambito; Nicola dell'Ombra; Roberto Di Marco; Roberto D Marco; Mariano Malaguarnera
Journal:  Am J Gastroenterol       Date:  2006-07-18       Impact factor: 10.864

10.  Kupffer cell aggregation and perivenular distribution in steatohepatitis.

Authors:  Jay H Lefkowitch; Jennifer H Haythe; Nicole Regent
Journal:  Mod Pathol       Date:  2002-07       Impact factor: 7.842

View more
  2 in total

1.  Effects of Chaihu-Shugan-San and Shen-Ling-Bai-Zhu-San on p38 MAPK Pathway in Kupffer Cells of Nonalcoholic Steatohepatitis.

Authors:  Qin-He Yang; Yong-Jian Xu; Yi-Zhen Liu; Yin-Ji Liang; Gao-Fei Feng; Yu-Pei Zhang; Hui-Jie Xing; Hai-Zhen Yan; Yuan-Yuan Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-25       Impact factor: 2.629

Review 2.  Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Authors:  Hor-Yue Tan; Serban San-Marina; Ning Wang; Ming Hong; Sha Li; Lei Li; Fan Cheung; Xiao-Yan Wen; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.